{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:15:42Z","timestamp":1740158142087,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ExC306","ExC306","ExC306"],"award-info":[{"award-number":["ExC306","ExC306","ExC306"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Werner-and-Klara Kreitz Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41423-020-0518-4","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T14:02:50Z","timestamp":1597932170000},"page":"1332-1335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNA methylation profile of a hepatosplenic gamma\/delta T-cell lymphoma patient associated with response to interferon-\u03b1 therapy"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-3125","authenticated-orcid":false,"given":"Jaydeep","family":"Bhat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke K.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-3593","authenticated-orcid":false,"given":"Silvio","family":"Waschina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Nerl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kaleta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Ammerpohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-7103","authenticated-orcid":false,"given":"Dieter","family":"Kabelitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"518_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of gamma delta T cells to immunology. Nat. Rev. Immunol. 13, 88\u2013100 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"518_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"518_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","volume":"74","author":"M Yabe","year":"2018","unstructured":"Yabe, M., Miranda, R. N. & Medeiros, L. J. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors. Hum. Pathol. 74, 5\u201316 (2018).","journal-title":"Hum. Pathol."},{"key":"518_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.critrevonc.2011.10.001","volume":"83","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri, A. J., Govi, S. & Pileri, S. A. Hepatosplenic gamma-delta T-cell lymphoma. Crit. Rev. Oncol.\/Hematol. 83, 283\u2013292 (2012).","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"518_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/0145-2126(92)90047-B","volume":"16","author":"R Metzger","year":"1992","unstructured":"Metzger, R., Heckl-Ostreicher, B., Nerl, C., Schondelmaier, S. & Kabelitz, D. Immunological studies of gamma delta T cells in a case of large granular lymphocyte (LGL) leukemia: leukemic gamma delta+ T cells are resistant to growth stimulation in vitro but respond to interferon-alpha treatment in vivo. Leuk. Res. 16, 1087\u20131095 (1992).","journal-title":"Leuk. Res."},{"key":"518_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2141.1996.d01-1779.x","volume":"94","author":"T Hinz","year":"1996","unstructured":"Hinz, T., Marx, S., Nerl, C. & Kabelitz, D. Clonal expansion of gamma delta T cells expressing two distinct T-cell receptors. Br. J. Haematol. 94, 62\u201364 (1996).","journal-title":"Br. J. Haematol."},{"key":"518_CR7","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.3324\/haematol.2018.196196","volume":"104","author":"AK Bergmann","year":"2019","unstructured":"Bergmann, A. K. et al. DNA methylation profiling identifies candidate genes for the pathogenesis of hepatosplenic T-cell lymphoma. Haematologica 104, e104\u2013e107 (2019).","journal-title":"Haematologica"},{"key":"518_CR8","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1073\/pnas.96.6.3092","volume":"96","author":"RV Iozzo","year":"1999","unstructured":"Iozzo, R. V. et al. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc. Natl. Acad. Sci. USA 96, 3092\u20133097 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"518_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/17460441.2016.1233176","volume":"11","author":"F Barbieri","year":"2016","unstructured":"Barbieri, F., Bajetto, A., Thellung, S., Wurth, R. & Florio, T. Drug design strategies focusing on the CXCR4\/CXCR7\/CXCL12 pathway in leukemia and lymphoma. Expert Opin. Drug Discov. 11, 1093\u20131109 (2016).","journal-title":"Expert Opin. Drug Discov."},{"key":"518_CR10","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1182\/blood-2010-08-258772","volume":"117","author":"JJ Kiladjian","year":"2011","unstructured":"Kiladjian, J. J., Mesa, R. A. & Hoffman, R. The renaissance of interferon therapy for the treatment of myeloid malignancies. Blood 117, 4706\u20134715 (2011).","journal-title":"Blood"},{"key":"518_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4701-2","volume":"18","author":"F Kordowski","year":"2018","unstructured":"Kordowski, F. et al. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers. BMC Cancer 18, 796 (2018).","journal-title":"BMC Cancer"},{"key":"518_CR12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/s41375-018-0369-5","volume":"33","author":"S Kollmann","year":"2019","unstructured":"Kollmann, S. et al. Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR\/ABL-induced leukemia. Leukemia 33, 1583\u20131597 (2019).","journal-title":"Leukemia"},{"key":"518_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1158\/1535-7163.MCT-15-0667","volume":"15","author":"WD Hedrich","year":"2016","unstructured":"Hedrich, W. D. et al. Activation of the constitutive androstane receptor increases the therapeutic index of CHOP in lymphoma Treatment. Mol. Cancer Therapeutics 15, 392\u2013401 (2016).","journal-title":"Mol. Cancer Therapeutics"},{"key":"518_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0641-1","volume":"11","author":"S Yao","year":"2019","unstructured":"Yao, S. et al. Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. Clin. Epigenetics 11, 45 (2019).","journal-title":"Clin. Epigenetics"},{"key":"518_CR15","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.201207-1280OC","volume":"186","author":"ES Wan","year":"2012","unstructured":"Wan, E. S. et al. Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186, 1248\u20131255 (2012).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"518_CR16","first-page":"129","volume":"1826","author":"S Chakraborty","year":"2012","unstructured":"Chakraborty, S., Kaur, S., Guha, S. & Batra, S. K. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochimica et. Biophysica Acta. 1826, 129\u2013169 (2012).","journal-title":"Biochimica et. Biophysica Acta."},{"key":"518_CR17","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1002\/eji.201142351","volume":"42","author":"A Schroll","year":"2012","unstructured":"Schroll, A. et al. Lipocalin-2 ameliorates granulocyte functionality. Eur. J. Immunol. 42, 3346\u20133357 (2012).","journal-title":"Eur. J. Immunol."},{"key":"518_CR18","doi-asserted-by":"publisher","first-page":"e1358839","DOI":"10.1080\/2162402X.2017.1358839","volume":"6","author":"G Chitadze","year":"2017","unstructured":"Chitadze, G. et al. In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment. Oncoimmunology 6, e1358839 (2017).","journal-title":"Oncoimmunology"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0518-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0518-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0518-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:09:23Z","timestamp":1629414563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0518-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-0518-4","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"type":"print","value":"1672-7681"},{"type":"electronic","value":"2042-0226"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}